Anya M. Lin

TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Corrigendum: A double-edged effect of hypoxia on astrocyte-derived exosome releases.

Corrigendum: A double-edged effect of hypoxia on astrocyte-derived exosome releases.

Journal: Experimental biology and medicine (Maywood, N.J.)
Published: July 02, 2025

A double-edged effect of hypoxia on astrocyte-derived exosome releases.

A double-edged effect of hypoxia on astrocyte-derived exosome releases.

Journal: Experimental biology and medicine (Maywood, N.J.)
Published: March 02, 2025

Involvement of EGFR-AKT signaling in hemin-induced neurotoxicity.

Involvement of EGFR-AKT signaling in hemin-induced neurotoxicity.

Journal: Experimental biology and medicine (Maywood, N.J.)
Published: February 27, 2025

Oral ellagic acid attenuated LPS-induced neuroinflammation in rat brain: MEK1 interaction and M2 microglial polarization.

Oral ellagic acid attenuated LPS-induced neuroinflammation in rat brain: MEK1 interaction and M2 microglial polarization.

Journal: Experimental biology and medicine (Maywood, N.J.)
Published: June 21, 2023

Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer.

Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer.

Journal: Pharmaceutics
Published: August 12, 2022

Gene-editing by CRISPR-Cas9 in combination with anthracycline therapy via tumor microenvironment-switchable, EGFR-targeted, and nucleus-directed nanoparticles for head and neck cancer suppression.

Gene-editing by CRISPR-Cas9 in combination with anthracycline therapy via tumor microenvironment-switchable, EGFR-targeted, and nucleus-directed nanoparticles for head and neck cancer suppression.

Journal: Nanoscale horizons
Published: July 29, 2021

Author Correction: Anti-inflammatory effect of afatinib (an EGFR-TKI) on OGD-induced neuroinflammation.

Author Correction: Anti-inflammatory effect of afatinib (an EGFR-TKI) on OGD-induced neuroinflammation.

Journal: Scientific reports
Published: January 26, 2021

Neuroprotective effect of selumetinib on acrolein-induced neurotoxicity.

Neuroprotective effect of selumetinib on acrolein-induced neurotoxicity.

Journal: Scientific reports
Published: November 11, 2020

Lysine Deprivation Induces AKT-AADAT Signaling and Overcomes EGFR-TKIs Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells.

Lysine Deprivation Induces AKT-AADAT Signaling and Overcomes EGFR-TKIs Resistance in EGFR-Mutant Non-Small Cell Lung Cancer Cells.

Journal: Cancers
Published: November 03, 2020

PEG-coated nanoparticles detachable in acidic microenvironments for the tumor-directed delivery of chemo- and gene therapies for head and neck cancer.

PEG-coated nanoparticles detachable in acidic microenvironments for the tumor-directed delivery of chemo- and gene therapies for head and neck cancer.

Journal: Theranostics
Published: February 21, 2020

Anti-inflammatory Effect of AZD6244 on Acrolein-Induced Neuroinflammation.

Anti-inflammatory Effect of AZD6244 on Acrolein-Induced Neuroinflammation.

Journal: Molecular neurobiology
Published: August 29, 2019

Gallic Acid Attenuated LPS-Induced Neuroinflammation: Protein Aggregation and Necroptosis.

Gallic Acid Attenuated LPS-Induced Neuroinflammation: Protein Aggregation and Necroptosis.

Journal: Molecular neurobiology
Published: August 29, 2019
Showing 1-12 of 33

Last Updated: 09/26/2026